Genesis Investment Properties News and Activities

Genesis Investment Properties is owned by Genesis Biotechnology Group.

Genesis Biotechnology Group has 3 subsidiaries including Genesis Drug Discovery & Development, Genesis Investment Properties and Medical Diagnostic Laboratories.

They are in:

• Biotechnology75%
• Real Estate25%

View the org chart displaying its 10 main executives

Most searched biographies at Genesis Investment Properties

• Eli Mordechai, Chief Executive Officer
• Elka Devash, Principal
• Sophia Lee, Director of Finance

Create your alert
to follow the executive moves at Genesis Investment Properties.

Genesis Biotechnology Group has 3,097 competitors including JLL (United States (USA)), CBRE Group (United States (USA)) and Apleona (Germany).

Popular M&A news in Real Estate

• Howard Hughes has acquired Vantage Group Holdings (posted on June 5 2026).
• CoStar has announced the acquisition of Zonda  (posted on May 30 2026).
• AvalonBay and Equity Residential have announced they will merge  (posted on May 22 2026)..

Popular contacts in Real Estate

• Elliott Aintabi - Chairman of the Board and Chief Executive Officer at Jesta Group
• Amit Jain - Group Chief Executive Officer at Emaar
• Stephen CuUnjieng - Director at Century Properties Group

Learn more about the Real Estate industry

Press releases by Genesis Investment Properties

• News | Genesis Investment Properties
• Genesis Investment Properties

Social media about Genesis Investment Properties

• Genesis Investment Properties on Wikipedia, Google News & Yahoo Finance
• Genesis Investment Properties on LinkedIn, X (Twitter) & YouTube